How much funding has Flag Therapeutics raised?

Flag Therapeutics has disclosed $1.4M raised across 2 rounds.

Where is Flag Therapeutics headquartered?

Flag Therapeutics is headquartered in Raleigh, US.

Flag Therapeutics

Raleigh, US · North Carolina corporation

Find your way into Flag Therapeutics

185 people in our graph share verified history with the Flag Therapeutics team — schools, employers, funds. One of them is your warm intro.

Ken Howardunlockedknows Frank L. Sorgi · together at Duquesne University (overlapped)

×2knows the team · via Duquesne University

×9knows the team · via University of Pittsburgh

FLAG Therapeutics develops drug delivery and dosage form solutions for pharmaceutical development and manufacturing, serving biotech and pharmaceutical companies in oncology and rare disease therapeutics.

Biotech Healthtech Medical Devices

Founders & leadership

RUHI AHMEDExecutive

Frank L. Sorgi inPresident and Chief Executive OfficerFrank L. Sorgi is President and CEO of FLAG Therapeutics, which develops drug delivery and dosage form solutions for pharmaceutical and biotech companies focused on oncology and rare disease therapeutics.

Reported raises · per SEC filings

Form D private placements

$1.4M disclosed across 2 rounds · 2016–2019

▶$72.5KraisedJul 2019 · 2 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

FRANK L. SORGIExecutive Officer, Director
RUHI AHMEDExecutive Officer

Offering amount: $3.5M
Amount sold: $72.5K
First sale: Jun 2019
Incorporated: Corporation, North Carolina
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1.3MraisedJan 2019 · 14 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

FRANK L. SORGIExecutive Officer, Director
RUHI AHMEDExecutive Officer

Offering amount: $1.3M
Amount sold: $1.3M
First sale: Mar 2016
Incorporated: Corporation, North Carolina
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Fate Therapeutics3 shared keywordsFate Therapeutics develops investigational cellular immunotherapies to treat autoimmune diseases and cancer. The company is conducting clinical trials on product candidates under strict regulatory and ethical standards.

Epicrispr Biotechnologies3 shared keywordsEpic CRISPR develops GEMS (Gene Expression Modulation System), a modular epigenetic editing platform that combines DNA-binding proteins, guide RNAs, and modulator proteins to create genetic medicines. The company serves the biotech/medtech sector with advanced tools for precise gene expression control and disease treatment.

Companies competing with Flag Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase II	2017	$1.5M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Raleigh oncology startup Flag Therapeutics raises $485,000 | WRAL TechWirewraltechwire.com · Oct 2018

Frequently asked questions

What does Flag Therapeutics do?: FLAG Therapeutics develops drug delivery and dosage form solutions for pharmaceutical development and manufacturing, serving biotech and pharmaceutical companies in oncology and rare disease therapeutics.
How much funding has Flag Therapeutics raised?: Flag Therapeutics has disclosed $1.4M raised across 2 rounds.
Where is Flag Therapeutics headquartered?: Flag Therapeutics is headquartered in Raleigh, US.